LMNB1

Chr 5AD

lamin B1

Also known as: ADLD, LMN, LMN2, LMNB, MCPH26

This gene encodes one of the two B-type lamin proteins and is a component of the nuclear lamina. A duplication of this gene is associated with autosomal dominant adult-onset leukodystrophy (ADLD). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 0.411 OMIM phenotype
Clinical SummaryLMNB1
🧬
Gene-Disease Validity (ClinGen)
microcephaly 26, primary, autosomal dominant · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.55) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
1 unique Pathogenic / Likely Pathogenic· 64 VUS of 98 total submissions
📖
GeneReview available — LMNB1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.41LOEUF
pLI 0.555
Z-score 3.92
OE 0.21 (0.110.41)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.63Z-score
OE missense 0.74 (0.660.82)
229 obs / 309.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.21 (0.110.41)
00.351.4
Missense OE?0.74 (0.660.82)
00.61.4
Synonymous OE?0.95
01.21.6
LoF obs/exp: 6 / 28.6Missense obs/exp: 229 / 309.5Syn Z: 0.41
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveLMNB1-related developmental disorderOTHERAD

This gene — mechanism propensity

DN
0.83top 10%
GOF
0.7127th %ile
LOF
0.3453th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median · 1 literature citation
GOFprediction above median · ClinGen TS: Sufficient evidence for dosage pathogenicity

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNDominant negative mutant lamin B proteins that disrupt lamin B assembly in interphase nuclei also disrupted spindle assembly in mitosis.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 16543417

ClinVar Variant Classifications

98 submitted variants in ClinVar

Classification Summary

Pathogenic1
VUS64
Likely Benign16
Conflicting1
1
Pathogenic
64
VUS
16
Likely Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
0
0
1
Likely Pathogenic
0
0
0
0
0
VUS
6
57
1
0
64
Likely Benign
0
4
3
9
16
Benign
0
0
0
0
0
Conflicting
1
Total6624982

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

1 pathogenic / likely-pathogenic (of 2) ClinVar copy-number / structural variants overlap LMNB1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

LMNB1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →